PLACON THERAPEUTICS
DEAD

Serial Number

86832158

Owner

Placon Therapeutics, Inc.

Attorney

Jenevieve Maerker

Filing Date

Nov 25, 2015

Add to watchlist:

No watchlists yet
View on USPTO

PLACON THERAPEUTICS Trademark

Serial Number: 86832158

PLACON THERAPEUTICS is a trademark filed by Placon Therapeutics, Inc. on November 25, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Placon Therapeutics, Inc. (2 trademarks)

134 Coolidge Avenue
Watertown, MA 02472

Entity Type: 03

Trademark Details

Filing Date

November 25, 2015

Registration Date

Not Registered

Published for Opposition

May 17, 2016

Goods & Services

Pharmaceuticals, namely, antineoplastics, anti-inflammatories, anti-infectives, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals, cardiovascular pharmaceuticals, dermatological pharmaceutical products, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment and prevention of diseases and disorders of the auto-immune system, the metabolic system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for use in hematology and in tissue and organ transplantation, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations for the treatment of kidney diseases, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating hypertension, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for use in urology, pharmaceutical products for ophthalmological use, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for treating respiratory diseases, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical preparations for the treatment of sleep disorders and neurological disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 12, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 12, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 16, 2019 EXRA
SOU EXTENSION 5 GRANTED
Jan 15, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 15, 2019 AITU
SOU EXTENSION 5 FILED
Jan 4, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 4, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 3, 2018 EXRA
SOU EXTENSION 4 GRANTED
Jun 29, 2018 EX4G
SOU EXTENSION 4 FILED
Jun 29, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 29, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 15, 2017 EXRA
SOU EXTENSION 3 GRANTED
Nov 13, 2017 EX3G
SOU EXTENSION 3 FILED
Nov 13, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 13, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2017 EXRA
SOU EXTENSION 2 GRANTED
May 15, 2017 EX2G
SOU EXTENSION 2 FILED
May 15, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
May 15, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2017 EXRA
SOU EXTENSION 1 GRANTED
Jan 6, 2017 EX1G
SOU EXTENSION 1 FILED
Jan 6, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 6, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 12, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2016 NPUB
PUBLISHED FOR OPPOSITION
May 17, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 27, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 25, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 25, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 25, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 25, 2016 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 23, 2016 GNRN
NON-FINAL ACTION E-MAILED
Mar 23, 2016 GNRT
NON-FINAL ACTION WRITTEN
Mar 23, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2015 NWOS
NEW APPLICATION ENTERED
Nov 28, 2015 NWAP